home / links / going deeper / health & safety / medicines & health services

youthXchange go
back to index

getting info
 > education & training
 > environment
 > fashion & beauty
 > food & drink
 > housing
 > job & volunteering
 > media
 > mobility
 > tests & games
 > tourism

going deeper
 > bio-cultural diversity
 > eco-awareness
 > health & safety
 > media literacy
 > free time
 > reports & statistics
 > sustainable design

taking action
 > biz & finance
 > creative lab
 > empowered consumers
 > enviro.org
 > labour & human rights
 > science & technology
 > sustainable communities

English site French site Korea site
air pollution | alcohol & drugs | alternative medicine | cancer | chemical safety | directories & portals | disabilities | environmental health | food safety | healthcare spending | health promotion | HIV/AIDS | hunger | malaria & tropical diseases | medicines & health services | nutrition/obesity | online check-ups | publications | sex & reproductive health | statistics | vaccinations | transport safety


recommended recommended
recommended recommended highly recommended
updated regularly updated
specialised or technical site specialised or technical site
YXC link to youthxchange content

print this page share with a friend send us your feedback

Drugs for Neglected Diseases Initiative (DNDI)- is a not-for-profit entity whose aim is developing drugs to care people suffering from neglected diseases and to make them accessible to the poorer patients of the world. And they really do an excellent job! [www.dndi.org] recommended YXC

“Improving Equity of Access to Medicines” - The issue of access to medicines by developing countries around the world is one of great significance. Good health is vital for the economic development of nations, and promoting the health of their citizens is one of the most important duties of governments… You’ll find here an interesting article written by Eric Noehrenberg and published by the United Nations Chronicle (Volume XL, Number 2, 2003). [www.un.org/Pubs/chronicle/2003/issue2/0203p12.html] YXC

MSF Campaign for Access to Essential Medicines - Today, one-third of the world’s population lacks access to essential medicines; in the poorest parts of Africa and Asia this figure rises to one-half. Since 1999, Médecins Sans Frontières (MSF) has been campaigning internationally to find long-term, sustainable solutions to this crisis. The Campaign is pushing to lower the prices of existing medicines, to bring abandoned drugs back into production, to stimulate research and development for diseases that primarily affect the poor, and to overcome other barriers to access. [www.accessmed-msf.org/campaign/campaign.shtm] recommended recommended YXC

MedWatch - This US Food and Drug Administration (FDA) website provides important and timely clinical information about safety issues involving medical products, including prescription and over-the-counter drugs, biologics, medical and radiation-emitting devices, and special nutritional products (e.g., medical foods, dietary supplements and infant formulas). Select ‘Safety Information’ to see reports, safety notifications, and labelling changes posted to the website since 1996. MedWatch allows healthcare professionals and consumers to report serious problems that they suspect are associated with the drugs and medical devices they prescribe, dispense, or use. Reporting can be done on line. [www.fda.gov/medwatch/index.html]

“Private sector and Health: Access to Medicines” - It is difficult to work with the private sector, but it is almost impossible to live without it. The relations between the private sector and NGOs on health issues and access to cheaper medicine have been all but easy. There are many issues to be resolved: access to essential drugs, unaffordable life-saving drugs, equitable drug prices, lack of R&D for neglected diseases, etc. Click here to get all the documents presented at the World Civil Society’s “Joint Working Group on Private Sector & Health” on July 2002. [www.worldcivilsociety.org/REPORT/EN/06/16-jul-02/summ_16.21.html] YXC

World Bank, “Improving Access to Medicines in Developing Countries” - The debate on improving access to medicines in developing countries has focused attention on the macroeconomic context and defining the demand side needs, based upon disease categories and purchasing power in a range of middle-income and Least Developed Countries. Far less attention has been given to understanding the diversity of supply side processes and their likely future evolution. This paper – published in March 2005 - examines alternative frameworks for empirical analysis of supply side activities, namely, the manufacture and distribution of medicine, through the application of New Institutional Economics (NIE) concepts. [http://siteresources.worldbank.org/HEALTHNUTRITIONANDPOPULATION/
] specialised or technical site YXC

WHO Drug Information is a quarterly journal providing an overview of topics relating to medicines development and regulation which is targeted to a wide audience of health professionals and policy makers. Launched in 1987, WHO Drug Information communicates the latest international news and trends to regulatory agencies, academic and training institutions, researchers, consumer bodies, and pharmaceutical manufacturers and focuses on topics impacting the safety, efficacy and quality of medicines, medical products, herbals and biomedicines. [www.who.int/druginformation]

WHO Drug Resistance - Drug resistance can be considered as a natural response to the selective pressure of the drug. However, it is exacerbated by several factors, including abuse, underuse or misuse of antimicrobials, poor patient compliance, and poor quality of available drugs. To respond to this threat, WHO has developed the first Global Strategy for Containment of Antimicrobial Resistance…[www.who.int/drugresistance/en] recommended

WHO Essential Drugs & Medicines - WHO’s goal in medicines is to help save lives and improve health by ensuring the quality, efficacy, safety and rational use of medicines, including traditional medicines, and by promoting equitable and sustainable access to essential medicines, particularly for the poor and disadvantaged. [www.who.int/medicines/en] recommended YXC

back to the top
[ home | UNEP/UNESCO contact | partners | YXC Team ]